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Introduction
The term “diffuse glioma” is currently used to describe as 
a special neoplastic pattern indicating a widespread brain 
invasion involving three or more cerebral lobes, frequent 
bilateral growth and possible extension to infratentorial 
structures, common to different glioma subtypes The 
term “gliomatosis”, formerly used in these cases, has been 
recently dismissed in the 2016 WHO classification (1,2). 
Here, we discuss the presentation and diagnosis of a diffuse 
glioblastoma in a young male who was initially suspected 
of having acute hemorrhagic leukoencephalitis (AHLE), a 
variant of acute disseminated encephalomyelitis (ADEM), 
and highlight the need of a synergic radiological and 
histological work-up to reach a correct diagnosis.
Case presentation
A previously healthy 24-year-old man presented with 
diplopia, concomitant with upper respiratory airway 
infection. He had no fever. The neurological examination 
showed right sixth cranial nerve paresis and dissociated 
nystagmus in the right lateral gaze. Brain MRI showed a 
hyperintense T2- and fluid-attenuated inversion recovery 
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Figure 1 Brain magnetic resonance axial FLAIR-weighted images obtained at the time of the AHLE diagnosis. Presence of scattered 
hyperintense areas involving the left thalamus and the bilateral temporal, peritrigonal and centrum semiovale white matter. FLAIR, fluid-
attenuated inversion recovery; AHLE, acute hemorrhagic leukoencephalitis.
(FLAIR)-weighted (w) oval area in the left thalamus, 
associated with involvement of bilateral deep temporal 
(mostly on the right side), left posterior temporal, and 
bilateral peritrigonal and centrum semiovale white matter 
(Figure 1). Twenty days later, MRI showed a slight disease 
progression, with involvement of the corpus callosum (CC), 
and heterogeneously hypointense focal lesions on T2-, 
Gradient-Echo (GE) T2* and FLAIR-w images, suggestive 
of hemorrhagic components (Figures 2,3). Some of these 
lesions showed restricted diffusion, particularly in the right 
peritrigonal region and in the left centrum semiovale. 
After contrast medium injection, mild enhancement of the 
periventricular ependyma and CC was observed (Figure 4), 
with marked increase in the relative cerebral blood 
volume (rCBV) (Figure 5). The hematochemical and 
microbiological tests of cerebrospinal fluid (CSF), including 
screening for JCV and HIV, were normal, and oligoclonal 
bands were absent. The spinal MRI and visual evoked 
Figure 2 Axial FLAIR-w images obtained twenty days later. Disease progression, with involvement of the corpus callosum, and evidence of 
a hypointense focal lesion in the right temporal lobe, suggestive of hemorrhagic components. FLAIR, fluid-attenuated inversion recovery.
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potentials were also normal. Additional tests on serum (celiac 
disease screening, neoplastic markers, autoimmune profile) 
and total-body CT scan were negative. The diagnosis of 
acute hemorrhagic leukoencephalitis (AHLE), an ADEM 
variant, was presumed and a treatment with high dose 
intravenous dexamethasone was started, but soon stopped 
due to intolerance and lack of clinical benefit. In the next 
few days the patient presented progressive clinical worsening 
with gait instability, ataxia, ophthalmoplegia, epilepsy and 
symptoms of intracranial hypertension. An open brain biopsy 
was thus performed in the area with the highest CBV value 
(right peritrigonal region, Figure 5, yellow arrows) and the 
histological diagnosis was glioblastoma (Figure 6). In view 
of the patient’s clinical status, imaging data, histological 
diagnosis, and lack of indication for radiotherapy, 
chemotherapy was started (Temozolomide 150 mg/m² qDay 
for 5 days, repeated at 28-day cycles). He remained clinically 
stable for one month, then rapidly deteriorated (Glasgow 
Coma Scale score: 6). Brain MRI showed severe progression 
of the disease with subependymal dissemination. For this 
reason, Temozolomide was stopped and palliative care was 
started. The patient died four months after the onset of 
Figure 3 GE T2*-w images on the coronal plane. Presence of hypointense focal areas in the corpus callosum (A), right temporal lobe (B), 
and right paratrigonal region (C) confirming the presence of hemorrhagic foci. GE, Gradient-Echo.
A B C
Figure 4 T1-w contrast-enhanced axial images corresponding to Figures 1 and 2. Mild enhancement of the periventricular ependyma and 
corpus callosum.
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neurological disease.
Discussion
This case initially showed several elements evocative of the 
rare and severe hemorrhagic variant of ADEM, which is an 
acute inflammatory demyelinating disease of the CNS (3). 
In fact, age at onset, concomitant airway infection, clinical 
presentation, and some features of the two initial brain 
MRIs (multifocal gray and white matter lesions associated 
with focal hemorrhage) were all suggestive of AHLE. The 
differential diagnosis included neoplastic disease, either 
lymphomatosis cerebri (LC) or diffuse glioma. LC is a 
rare variant of primary CNS lymphoma, characterized on 
MRI by a diffuse infiltration of the cerebral white matter, 
with variable contrast enhancement at the early stage 
and frequent extension of the lesions to the brainstem, 
thalamus, and basal ganglia (4). LC typically shows a good 
response to pulse steroid therapy. This diagnosis was 
initially hypothesized but later excluded during the clinical 
and radiological follow-up. Diffuse glioblastoma is a rare 
condition, often presenting with a variety of signs and 
symptoms that may mimic other diseases. The involvement 
of at least three cerebral lobes by an infiltrative tissue, the 
lack of a single discrete mass and pathological confirmation 
of diffuse glioma (WHO grade IV) indicate the diagnosis. 
However, the imaging features may also be present in 
CNS inflammatory diseases, vasculitis, encephalitis, 
leukoencephalopathies, especially when there is no obvious 
mass effect (2,5-10). While cases of demyelinating diseases 
mimicking gliomas are well represented in the literature 
(11,12), the opposite is a rather rare occurrence, mainly 
reported in the pediatric (13-15) or young (16) age. Thus, 
clinical and radiological features should be the first data 
directing the treating physician, as histological confirmation 
obtained through biopsy may provide a partial picture 
of the tumor (15). Diffuse glioma presents with diffuse, 
poorly-defined hyperintense lesions on T2-w and FLAIR 
images, and with variable contrast-enhancement, making 
imaging studies sometimes rather nonspecific; in these 
Figure 5 Dynamic susceptibility contrast MR perfusion. CBV map shows areas of increased rCBV in the right temporal lobe, right 
peritrigonal region and in the periventricular ependyma (yellow arrows). CBV, cerebral blood volume; rCBV, relative cerebral blood volume.
Figure 6 Hematoxylin-eosin staining showing essential 
morphologic features for the diagnosis of glioblastoma (GBM): 
necrosis and endothelial proliferation. Nuclear atypia, cellular 
pleomorphism and mitotic activity are also visible (H&E, 20×).
596
© Quantitative Imaging in Medicine and Surgery. All rights reserved. Quant Imaging Med Surg 2017;7(5):592-597qims.amegroups.com
Schettino et al. Glioblastoma resembling hemorrhagic leukoencephalitis
cases, the integration of functional (spectroscopy, perfusion) 
and morphological information is helpful in guiding the 
bioptic procedure (17). Diffuse expansion of the CC, mass 
effect, and progressive deterioration during follow-up may 
be considered characteristic. Therefore, we emphasize 
the need to maintain diffuse glioma in the differential 
diagnosis of patients with an encephalitis-type presentation; 
possibly considering the need of biopsy in either clinical or 
neuroradiologic equivocal cases.
Diffuse glioma usually predominates in the white matter: 
interestingly, a major involvement of the gray matter is 
associated to increased response to chemotherapy (18). 
However, the prognosis is poor, with somewhat better 
outcome associated with a low grade histology, young age, 
and good performance status (19). No consensus on the 
treatment is available at present, so that therapeutic choices 
should be tailored to each individual case (20).
Conclusions
In conclusion, this case highlights the diagnostic difficulties 
of diffuse gliomas when clinical and radiological features 
are not specific. Diffuse gliomas and AHLE are both rare 
and severe entities, but the differential diagnosis is very 
important because the use of various combinations of 
immunosuppressive agents in the latter (corticosteroids, 
immunoglobulin, plasmapheresis and cyclofosfamide) 
proved beneficial in some cases. MRI can establish the 
diagnosis in an appropriate clinical setting, but a histological 
definition may be necessary to confirm the diagnosis, 
possibly guided by functional information.
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